ECHINOMYCIN (NSC-526417) IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP

被引：23
作者：
MUSS, HB
BLESSING, JA
MALFETANO, J
机构：
[1] ALBANY MED CTR,DEPT OBSTET & GYNECOL,ALBANY,NY
[2] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT MED,WINSTON SALEM,NC 27103
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,DEPT STAT,BUFFALO,NY 14263
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1990年 / 13卷 / 03期
关键词：
D O I：
10.1097/00000421-199006000-00002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Twenty-eight evaluable patients with advanced or recurrent squamous-cell carcinoma of the cervix were treated with 1,500 μg/m2 of echinomycin every 4 weeks. All patients had prior chemotherapy. Two patients had partial responses (7% response, 95% confidence interval for response of 1 to 24%). The major toxicity was nausea and vomiting. Myelosuppression and other toxicity were modest. Echinomycin, at this dose and schedule, displays minimal activity in patients with squamous-cell carcinoma of the cervix who have had prior chemotherapy.
引用
收藏
页码：191 / 193
页数：3
相关论文
共 50 条
[41]   Phase II trial of bevacizumab in the treatment of recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study [J].
Monk, B. J. ;
Sill, M. W. ;
Burger, R. A. ;
Gray, H. J. ;
Buekers, T. E. ;
Roman, L. D. .
GYNECOLOGIC ONCOLOGY, 2008, 108 (03) :S21-S22
[42]   A Phase II Trial of Pyrazoloacridine (PZA) in Squamous Carcinoma of the Cervix – A Gynecologic Oncology Group Study [J].
Steven C. Plaxe ;
John A. Blessing ;
Joseph A. Lucci ;
Jean A. Hurteau .
Investigational New Drugs, 2001, 19 :77-80
[43]   AMINOTHIADIAZOLE (NSC-4728) IN PATIENTS WITH ADVANCED NONSQUAMOUS CARCINOMA OF THE CERVIX - A PHASE-II STUDY OF THE GYNECOLOGIC ONCOLOGY GROUP [J].
ASBURY, RF ;
BLESSING, JA ;
DISAIA, PJ ;
MALFETANO, J .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (05) :375-377
[44]   PALA (NSC-224131) IN ADVANCED-CARCINOMA OF THE CERVIX - A PHASE-II STUDY OF THE GYNECOLOGIC-ONCOLOGY-GROUP [J].
MUSS, HB ;
BUNDY, B ;
DISAIA, PJ ;
STEHMAN, FB ;
BEECHAM, J .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (06) :741-744
[45]   Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group [J].
Muggia, FM ;
Blessing, JA ;
McGehee, R ;
Monk, BJ .
GYNECOLOGIC ONCOLOGY, 2004, 94 (02) :483-487
[46]   MITOXANTRONE FOR CARCINOMA OF THE ENDOMETRIUM - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP [J].
MUSS, HB ;
BUNDY, BN ;
DISAIA, PJ ;
EHRLICH, CE .
CANCER TREATMENT REPORTS, 1987, 71 (02) :217-218
[47]   PHASE-II STUDY OF VINBLASTINE IN PREVIOUSLY TREATED SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SUTTON, GP ;
BLESSING, JA ;
BARNES, W ;
BALL, H .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06) :470-471
[48]   Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study [J].
Monk, Bradley J. ;
Sill, Michael W. ;
Burger, Robert A. ;
Gray, Heidi J. ;
Buekers, Thomas E. ;
Roman, Lynda D. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) :1069-1074
[49]   PHASE-II TRIAL OF ICRF-159 IN TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX [J].
CONROY, J ;
BLESSING, J ;
LEWIS, G ;
MANGAN, C ;
HATCH, K ;
WILBANKS, G .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR) :423-423
[50]   PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
SLAYTON, RE ;
BLESSING, JA ;
HOMESLEY, HD .
CANCER TREATMENT REPORTS, 1984, 68 (12) :1513-1514
12345